Share on StockTwits
 

AstraZeneca (LON:AZN) is scheduled to issue its quarterly earnings data on Thursday, February 6th. Persons that wish to listen to the company’s earnings conference call can do so using this link.

AstraZeneca (LON:AZN) opened at 3873.00 on Wednesday. AstraZeneca has a 52-week low of GBX 2895.00 and a 52-week high of GBX 3964.50. The stock’s 50-day moving average is GBX 3713.09 and its 200-day moving average is GBX 3383.62. The company’s market cap is £48.529 billion.

A number of analysts have recently weighed in on AZN shares. Analysts at Nordea Equity Research reiterated a “buy” rating on shares of AstraZeneca in a research note to investors on Friday, January 31st. They now have a GBX 4,469.30 ($73.45) price target on the stock. On the ratings front, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of AstraZeneca in a research note to investors on Tuesday, January 28th. They now have a GBX 3,700 ($60.81) price target on the stock. Finally, analysts at Deutsche Bank reiterated a “hold” rating on shares of AstraZeneca in a research note to investors on Friday, January 24th. They now have a GBX 3,600 ($59.16) price target on the stock. Twelve research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of GBX 3,369.96 ($55.38).

AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.